Peng-cheng He

Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia.

Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia.

Journal: Science translational medicine
Published: May 06, 2026

Site-specific methylation of SRSF2P95H by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome.

Site-specific methylation of SRSF2P95H by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome.

Journal: Science translational medicine
Published: April 01, 2026

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Journal: Cancer letters
Published: November 02, 2025

Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma.

Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma.

Journal: Cell transplantation
Published: October 31, 2025

The Efficacy of Combination of Avatrombopag and rhIL-11 in Adult Patients of Acute Myeloid Leukemia with Cancer Treatment-Induced Thrombocytopenia

The Efficacy of Combination of Avatrombopag and rhIL-11 in Adult Patients of Acute Myeloid Leukemia with Cancer Treatment-Induced Thrombocytopenia

Journal: Zhongguo shi yan xue ye xue za zhi
Published: July 04, 2025

Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia.

Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia.

Journal: The oncologist
Published: January 08, 2025

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Journal: Blood advances
Published: January 02, 2025

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Journal: Blood advances
Published: January 02, 2025

Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: A CBMTR Registry-based propensity score matching analysis over the last decade.

Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: A CBMTR Registry-based propensity score matching analysis over the last decade.

Journal: Cancer letters
Published: November 25, 2024

Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study.

Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study.

Journal: Bone marrow transplantation
Published: September 24, 2024

SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis.

SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis.

Journal: Developmental cell
Published: November 14, 2023

The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group.

The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry group.

Journal: Haematologica
Published: October 31, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026